54864-89-0 Usage
Uses
Used in Pharmaceutical Industry:
6-(4-METHYLPIPERAZIN-1-YL)NICOTINONITRILE is used as a potential drug candidate for the development of pharmaceuticals targeting various diseases and conditions. Its unique structure allows it to potentially act as a ligand for specific receptors or enzymes, which can be harnessed for therapeutic purposes.
Used in Chemical Synthesis:
6-(4-METHYLPIPERAZIN-1-YL)NICOTINONITRILE is used as a building block or intermediate in the synthesis of other organic compounds. Its versatile structure can be further modified or combined with other molecules to create new compounds with specific properties and applications.
Used in Research and Development:
6-(4-METHYLPIPERAZIN-1-YL)NICOTINONITRILE is used as a research compound to study its biological activity and pharmacological properties. Further research is needed to understand its interaction with biological targets and to determine its potential as a therapeutic agent.
Check Digit Verification of cas no
The CAS Registry Mumber 54864-89-0 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 5,4,8,6 and 4 respectively; the second part has 2 digits, 8 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 54864-89:
(7*5)+(6*4)+(5*8)+(4*6)+(3*4)+(2*8)+(1*9)=160
160 % 10 = 0
So 54864-89-0 is a valid CAS Registry Number.
InChI:InChI=1/C11H14N4/c1-14-4-6-15(7-5-14)11-3-2-10(8-12)9-13-11/h2-3,9H,4-7H2,1H3
54864-89-0Relevant academic research and scientific papers
Benzoquinone derivative, pharmaceutical composition, and applications thereof
-
Paragraph 0213-0216, (2019/11/29)
The invention discloses a benzoquinone derivative, a pharmaceutical composition, and applications thereof. According to the invention, the benzoquinone derivative (I), and the stereoisomer or the pharmaceutically acceptable salt thereof possess a structure disclosed in the invention. The benzoquinone derivative possesses excellent inhibition effect on STAT3 level both in vivo and in vitro, and further, the benzoquinone derivative is capable of inhibiting balling capacity of cancer cells.
2-(4-Methyl-piperazino)-3 or 5 cyano pyridine
-
, (2008/06/13)
This invention relates to compounds of the formula SPC1 Wherein R1 in the 3- or 5-position is a cyano group whereas R2 and in the 2-position is a N-methyl-piperazinyl group. Said compounds may be used as anti-inflammatory and cardiovascular agents.
C-Piperazino-pyridine sulfonamides
-
, (2008/06/13)
This invention relates to compounds of the formula: SPC1 Wherein R1 in the 3- or 5-position is preferably a substituted sulfonamido or a carboxamido group whereas R2 in the 2-, 4- or 6-position is preferably an alkyl- or hydroxyalkyl-piperazinyl group. Said compounds may be used as anti-inflammatory and cardiovascular agents.
